We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Owlstone Medical

News List

Owlstone Medical’s breath biopsy test improves detection of liver disease pharmatimes
September 27, 2020
Cambridge-based Owlstone Medical has announced new results from a study of its breath-based diagnostic test for liver disease, including Nonalcoholic Fatty Liver Disease (NAFLD) and associated Nonalcoholic steatohepatitis (NASH).
Owlstone Medical explores breath-based testing for more diseases pharmatimes
June 18, 2019
Owlstone Medical has announced that it’s investigating a novel approach to breath-based testing for the onset, progression, and treatment of various diseases.
Owlstone Medical, Actelion team up for pulmonary hypertension detection pharmatimes
May 20, 2019
Owlstone Medical has announced a strategic partnership with Actelion Pharmaceuticals.
Owlstone Medical Raises $15 Million USD (£11 million GBP) To Drive Commercialization of Its Breath B biospace
March 06, 2018
Owlstone Medical Ltd., a diagnostics company developing a breathalyzer for disease, announced today that it has raised $15 million (£11 million) to drive the global commercialization of its Breath Biopsy® platform.